Mental Health Funding Gets Private NIH Once-Over
Published Date: 3/19/2025
Notice
Summary
The National Institute of Mental Health is holding a private virtual meeting on April 21 and April 30, 2025, to review grant applications for non-drug clinical trials. This meeting affects researchers seeking funding and keeps sensitive info safe. No money changes are announced, but these reviews help decide who gets research grants.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NIMH grant reviews scheduled April 2025
If you are a researcher applying for National Institute of Mental Health (NIMH) non‑pharmacological clinical trials grants, your applications will be reviewed in a closed virtual panel on April 21, 2025 (12:00 p.m. to 4:00 p.m.) and April 30, 2025 (1:00 p.m. to 2:30 p.m.). The panel’s agenda is to review and evaluate grant applications, and its evaluations help decide who receives research grants; no specific funding amounts were announced.
Review meeting closed to protect confidential material
The April 21 and April 30, 2025 meetings will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information of applicants, so the public cannot attend or observe the review discussions.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17899, Proposed Collection; 60-Day Comment Request; Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report (Office of the Director)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the Office of Laboratory Animal Welfare (OLAW) in the Office of Extramural Research (OER) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-17687, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in October 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, ensuring fair and confidential decisions. Scientists applying for grants in genetics, molecular sciences, oral health, and cancer research are the ones affected, with no direct cost changes announced.
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
Previous / Next Documents
Previous: 2025-04602, National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 9, 2025, to review and decide on important grant applications for clinical trials and research projects. This meeting affects researchers seeking funding and helps protect private info and trade secrets. No public access means the money and project plans stay confidential while moving science forward.
Next: 2025-04604, Notice of Funds Availability (NOFA); Emergency Commodity Assistance Program (ECAP)
The Farm Service Agency is rolling out the Emergency Commodity Assistance Program (ECAP) to help farmers growing certain crops in 2024. Eligible producers can get economic aid based on their losses, with clear rules on who qualifies and how to apply using a simple, mostly pre-filled form. This new program kicks off thanks to the American Relief Act, 2025, so farmers should act fast to grab their share of the funds!